Photobiomodulation Ranks Among “Hot Topics” in Laser Medicine
For Immediate Release
March 23, 2013, Wausau, WI – “Hot Topics” at Laser 2013 will include a Photobiomodulation Session on Friday, April 5 and Saturday, April 6 as part of the 33rd Annual Conference of the American Society for Laser Medicine & Surgery, Inc. (ASLMS), April 3-7, 2013, Boston, MA.
The purpose of the sessions is to present and discuss the latest findings on light tissue interaction and basic mechanisms of photobiomodulation, pre-clinical and clinical investigations on the critical parameters, mechanisms, and effectiveness of light as a therapy for a broad range of clinical applications.
“The photobiomodulation sessions will provide up-to-date information on the underlying science and medical benefits of low-level laser therapy. The preclinical and clinical evidence for exciting new applications of photobiomodulation will be presented including treatment of central nervous system injury and disease, neuropathic pain, and cartilage damage due to osteoarthritis. Research will be presented on the use of photobiomodulation as an effective, adjunctive therapy during cardiac and spinal surgery to accelerate healing and reduce post-surgical complications and patient recovery time. Experimental evidence on the novel use of organic LEDs for effective treatment of chronic cutaneous wounds will be presented. A common thread throughout the photobiomodulation sessions is the effectiveness of low level laser therapy as a non-invasive treatment that alters inflammatory responses, accelerates healing and does not have the negative side effects normally associated with pharmacological agents,” noted Juanita J. Anders, Ph.D., Session Director. Dr. Anders is a Professor of Anatomy, Physiology and Genetics and Professor of Neuroscience at Uniformed Services University of the Health Sciences. She has held positions within ASLMS since 1991 including, vice president, committee chair, board member, and member of the executive committee.
The sessions are designed for scientists, engineers, medical practitioners, individuals in industry and other health care professionals involved in biomedical applications of light. Session participants should have an understanding of light interaction with biological tissues and basic and clinical research.
“The photobiomodulation sessions at the conference will provide up-to-date information on the underlying science and medical benefits of low-level laser (light) therapy. Particular attention will be paid to the applications of photobiomodulation in dermatology, neurology (including traumatic brain injury and pain reduction), wound healing, kidney disease, and lung function. In the future, many of these medical applications may be performed using inexpensive home-use consumer devices containing safe effective light-emitting diodes,” said Michael R. Hamblin, Ph.D., Co-Director. Dr. Hamblin is an Associate Professor in the Department of Dermatology at Harvard Medical School, Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, and Member of Affiliated Faculty at the Harvard-MIT Division of Health Science and Technology.
Maria Cristina Chavantes, M.D., Ph.D. will also serve as Co-Director.
Conference Registration is $490 for members or applicants, $525 for active members of the U.S. military and $750 for non-members. Students and residents are admitted free of charge.
To register or for more information visit www.aslms.org/annualconference/annualconference, call 877-258-6028 or email firstname.lastname@example.org.
The American Society for Laser Medicine and Surgery, Inc. (ASLMS) is the world's largest scientific organization dedicated to promoting research, education and high standards of clinical care in the field of medical laser applications. It provides a forum for the exchange of scientific information and participates in communicating the latest developments in laser medicine and surgery to clinicians, research investigators, government and regulatory agencies, and the public.